Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-27T14:29:04.734Z Has data issue: false hasContentIssue false
  • English
  • Français

Isolated adult Langerhans' cell histiocytosis in cervical lymph nodes: should it be treated?

Published online by Cambridge University Press:  02 December 2008

W-C Lo ,
C-C Chen ,
C-C Tsai  and
P-W Cheng
W-C Lo
Affiliation:
Department of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan
C-C Chen
Affiliation:
Department of Otolaryngology, Far Eastern Memorial Hospital, Taipei, Taiwan
C-C Tsai
Affiliation:
Department of Pathology, Far Eastern Memorial Hospital, Taipei, Taiwan
P-W Cheng*
Affiliation:
Department of Otolaryngology, Far Eastern Memorial Hospital, Taipei, Taiwan Department of Nursing, Oriental Institute of Technology, Taipei, Taiwan
*
Address for correspondence: Dr Po-Wen Cheng, Department of Otolaryngology, Far Eastern Memorial Hospital, 21, Section 2, Nan-Ya South Road, Pan Chiao, Taipei, Taiwan220. Fax: +886 2 89665567 E-mail: powenjapan@yahoo.com.tw
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

We report an extremely rare case of Langerhans' cell histiocytosis involving isolated cervical lymph nodes, and we discuss the diagnosis and treatment of this infrequent disease.

Method:

We present a case report and literature review concerning this disease entity.

Results:

A 54-year-old man presented with persistent, multiple, left neck masses. Histopathological study of lymph node specimens showed proliferation of Langerhans' cells coupled with eosinophilic and neutrophilic microabscesses. Positive immunohistochemical staining for Cluster of Differentiation 1a (CD1a) in Langerhans' cells confirmed the diagnosis. No other abnormalities were noted on a series of image studies. The patient was managed with ‘watchful waiting’ without subsequent therapy. The neck lesions regressed gradually over time, and the patient did well over a two-year follow-up period.

Conclusion:

The clinical presentation of Langerhans' cell histiocytosis is highly variable, and the choice of treatment depends on the involved organs. Definitive diagnosis depends on identification of characteristic immunohistochemical or ultrastructural features of the biopsy specimen. Watchful waiting may be an effective management strategy in cases of adult isolated lymph node Langerhans' cell histiocytosis, due to its possible spontaneous regression.

Keywords

Langerhans' Cell HistiocytosisLymph NodeAdultImmunohistochemistry
Type
Clinical Records
Information
The Journal of Laryngology & Otology , Volume 123 , Issue 9 , September 2009 , pp. 1055 - 1057
Copyright
Copyright © JLO (1984) Limited 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Favara, BE, Feller, AC, Pauli, M, Jaffe, ES, Weiss, LM, Arico, M, et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997;29:157–663.0.CO;2-C>CrossRefGoogle Scholar
2 Fleming, MD, Pinkus, JL, Fournier, MV, Alexander, SW, Tam, C, Loda, M et al. Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood 2003;101:2473–5CrossRefGoogle ScholarPubMed
3 Hoover, KB, Rosenthal, DI, Mankin, H. Langerhans cell histiocytosis. Skeletal Radiol 2007;36:95–104CrossRefGoogle ScholarPubMed
4 Aricò, M. Langerhans cell histiocytosis in adults: more questions than answers? Eur J Cancer 2004;40:1467–73CrossRefGoogle ScholarPubMed
5 Marioni, G, De Filippis, C, Stramare, R, Carli, M, Staffieri, A. Langerhans' cell histiocytosis: temporal bone involvement. J Laryngol Otol 2001;115:839–41CrossRefGoogle ScholarPubMed
6 Stockschlaeder, M, Sucker, C. Adult Langerhans cell histiocytosis. Eur J Haematol 2006;76:363–8Google Scholar
7 Aricò, M, Girschikofsky, M, Généreau, T, Klersy, C, McClain, K, Grois, N et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 2003;39:2341–8Google Scholar
8 Howarth, DM, Gilchrist, GS, Mullan, BP, Wiseman, GA, Edmonson, JH, Schomberg, PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999;85:2278–90Google Scholar
9 Arceci, RJ, Brenner, MK, Pritchard, J. Controversies and new approaches to treatment of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:339–57CrossRefGoogle ScholarPubMed
10 Mottl, H, Ganevová, M, Radvanská, J, Chánová, M, Smelhaus, V, Kodet, R et al. Treatment results of Langerhans cell histiocytosis with LSH II protocol [in Czech]. Cas Lek Cesk 2005;144:753–5Google ScholarPubMed
11 Baumgartner, I, von Hochstetter, A, Baumert, B, Luetolf, U, Follath, F. Langerhans'-cell histiocytosis in adults. Med Pediatr Oncol 1997;28:9–14Google Scholar